Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume -, Issue -, Pages 201814685
Publisher
Proceedings of the National Academy of Sciences
Online
2019-03-21
DOI
10.1073/pnas.1814685116
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box
- (2018) R. S. Jumani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Drug targeting of one or more aminoacyl-tRNA synthetase in the malaria parasite Plasmodium falciparum
- (2018) Yogavel Manickam et al. DRUG DISCOVERY TODAY
- Challenges and recent progress in drug discovery for tropical diseases
- (2018) Manu De Rycker et al. NATURE
- Necessity of Bumped Kinase Inhibitor Gastrointestinal Exposure in Treating Cryptosporidium Infection
- (2017) Samuel L. M. Arnold et al. JOURNAL OF INFECTIOUS DISEASES
- Structural characterization of human aminoacyl-tRNA synthetases for translational and nontranslational functions
- (2017) Pengfei Fang et al. METHODS
- A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis
- (2017) Ujjini H. Manjunatha et al. NATURE
- Childhood stunting in relation to the pre- and postnatal environment during the first 2 years of life: The MAL-ED longitudinal birth cohort study
- (2017) PLOS MEDICINE
- Structure-Based Targeting of Orthologous Pathogen Proteins Accelerates Antiparasitic Drug Discovery
- (2017) Vitul Jain et al. ACS Infectious Diseases
- Diversity-oriented synthesis yields novel multistage antimalarial inhibitors
- (2016) Nobutaka Kato et al. NATURE
- BRENDA in 2017: new perspectives and new tools in BRENDA
- (2016) Sandra Placzek et al. NUCLEIC ACIDS RESEARCH
- The Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS)
- (2016) Samba O. Sow et al. PLoS Neglected Tropical Diseases
- Cryptosporidiosis Drug Discovery: Opportunities and Challenges
- (2016) Ujjini H. Manjunatha et al. ACS Infectious Diseases
- Structural Basis for Specific Inhibition of tRNA Synthetase by an ATP Competitive Inhibitor
- (2015) Pengfei Fang et al. CHEMISTRY & BIOLOGY
- A novel multiple-stage antimalarial agent that inhibits protein synthesis
- (2015) Beatriz Baragaña et al. NATURE
- Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum
- (2015) Sumiti Vinayak et al. NATURE
- Selective Inhibition of an Apicoplastic Aminoacyl-tRNA Synthetase fromPlasmodium falciparum
- (2013) Rob Hoen et al. CHEMBIOCHEM
- Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study
- (2013) Karen L Kotloff et al. LANCET
- Selective and Specific Inhibition of the Plasmodium falciparum Lysyl-tRNA Synthetase by the Fungal Secondary Metabolite Cladosporin
- (2012) Dominic Hoepfner et al. Cell Host & Microbe
- Asymmetric Total Synthesis of Cladosporin and Isocladosporin
- (2012) Huaiji Zheng et al. JOURNAL OF ORGANIC CHEMISTRY
- P. falciparum In Vitro Killing Rates Allow to Discriminate between Different Antimalarial Mode-of-Action
- (2012) Laura M. Sanz et al. PLoS One
- A genomic glimpse of aminoacyl-tRNA synthetases in malaria parasite Plasmodium falciparum
- (2010) Tarun Bhatt et al. BMC GENOMICS
- Thousands of chemical starting points for antimalarial lead identification
- (2010) Francisco-Javier Gamo et al. NATURE
- Improved Murine Model of Malaria Using Plasmodium falciparum Competent Strains and Non-Myelodepleted NOD-scid IL2R null Mice Engrafted with Human Erythrocytes
- (2009) M. B. Jimenez-Diaz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial
- (2009) Beatrice Amadi et al. BMC INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More